Baseline characteristics
| Characteristic . | N = 53 . |
|---|---|
| Age | |
| Median, y (range) | 59 (35-81) |
| ≥ 65 y, n (%) | 23 (43) |
| Sex | |
| Male, n (%) | 39 (74) |
| Female | 14 (26) |
| ISS stage, n (%) | |
| I | 21 (40) |
| II | 18 (34) |
| III | 14 (26) |
| Durie-Salmon stage, n (%) | |
| I | 7 (13) |
| II | 12 (24) |
| III | 34 (63) |
| Unfavorable cytogenetics, n (%)* | 17/51 (33) |
| del 13†/hypodiploidy | 10/50 (20) |
| t(4;14) | 5/49 (10) |
| t(14;16) | 0/48 (0) |
| del 17p | 7/48 (15) |
| Characteristic . | N = 53 . |
|---|---|
| Age | |
| Median, y (range) | 59 (35-81) |
| ≥ 65 y, n (%) | 23 (43) |
| Sex | |
| Male, n (%) | 39 (74) |
| Female | 14 (26) |
| ISS stage, n (%) | |
| I | 21 (40) |
| II | 18 (34) |
| III | 14 (26) |
| Durie-Salmon stage, n (%) | |
| I | 7 (13) |
| II | 12 (24) |
| III | 34 (63) |
| Unfavorable cytogenetics, n (%)* | 17/51 (33) |
| del 13†/hypodiploidy | 10/50 (20) |
| t(4;14) | 5/49 (10) |
| t(14;16) | 0/48 (0) |
| del 17p | 7/48 (15) |